1. Market Research
  2. > All Companies
  3. > Terumo Corporation (4543) - Financial and Strategic SWOT Analysis Review

Terumo Corporation (4543) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Terumo Corporation (Terumo) is a medical technology company. It undertakes the manufacturing and selling of a wide range of medical care products which include hospital and medical products, equipment and pharmaceuticals. Its major products include vascular interventional products, cardiovascular surgical systems, artificial vascular grafts, blood transfusion systems, infusions systems, nutritious food, diabetes monitoring and treatment devices, cancer pain management systems, home oxygen therapy systems and consumer healthcare products. The company conducts its operations in three divisions, namely, General Hospital business, Cardiac and Vascular business, and Blood Management business. Terumo conducts its operations through subsidiaries and associates in Japan, Europe, Americas and Asia-Pacific. The company is headquartered in Tokyo, Japan.

Terumo Corporation Key Recent Developments

May 19, 2015: Terumo Announces CE Mark Clearance for Bioresorbable Scaffold Developed by Arterial Remodeling Technologies
Apr 17, 2015: Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant
Apr 06, 2015: Terumo and Olympus Expand Interventional System Business Partnership
Mar 19, 2015: Scientists at Nelson Laboratories Discover Extractable Positive Control for In Vitro Skin Irritation Testing of Medical Devices
Feb 12, 2015: Terumo Establishes a New RD Center for Interventional Business in Southern California, US to Accelerate Worldwide Growth of Interventional Therapeutic Area

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table Of Contents

Terumo Corporation (4543) - Financial and Strategic SWOT Analysis Review
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Terumo Corporation - Key Facts 6
Terumo Corporation - Key Employees 7
Terumo Corporation - Key Employee Biographies 10
Terumo Corporation - Key Operational Employees 11
Terumo Corporation - Major Products and Services 12
Terumo Corporation - Medical Equipment Pipeline Products Data 14
Terumo Corporation Pipeline Products by Equipment Type 14
Terumo Corporation Pipeline Products by Development Stage 17
Terumo Corporation - History 19
Terumo Corporation - Company Statement 26
Terumo Corporation - Locations And Subsidiaries 27
Head Office 27
Other Locations and Subsidiaries 27
Joint Venture 30
Section 2 - Company Analysis 31
Terumo Corporation - Business Description 31
Business Description - Blood Transfusion Products 31
Blood Transfusion Products - Overview 31
Blood Transfusion Products - Financials 31
Business Description - Cardiac and Vascular Products 31
Cardiac and Vascular Products - Overview 31
Cardiac and Vascular Products - Financials 31
Cardiac and Vascular Products - Market View 31
Business Description - General Hospital Products 32
General Hospital Products - Overview 32
General Hospital Products - Financials 32
General Hospital Products - Market View 32
Terumo Corporation - Corporate Strategy 33
Terumo Corporation - SWOT Analysis 34
SWOT Analysis - Overview 34
Terumo Corporation - Strengths 34
Strength - Focused Research and Development Activities 34
Strength - Cardiac and Vascular Franchise 34
Strength - Strong Presence in International Markets 34
Terumo Corporation - Weaknesses 35
Weakness - Product Safety Concerns 35
Weakness - Substantial Debt 35
Terumo Corporation - Opportunities 36
Opportunity - The US FDA 510(k) Clearances 36
Opportunity - Increasing Cardiovascular Diseases 36
Opportunity - Strategic Initiatives 36
Terumo Corporation - Threats 38
Threat - Rise in Raw Material Prices 38
Threat - Intense Competition 38
Threat - Rapid Technological Changes 38
Threat - Stringent Government Regulations 38
Terumo Corporation - Key Competitors 39
Section 3 - Company Financial Ratios 40
Financial Ratios - Capital Market Ratios 40
Financial Ratios - Annual Ratios 41
Performance Chart 43
Financial Performance 43
Financial Ratios - Interim Ratios 44
Financial Ratios - Ratio Charts 45
Section 4 - Company's Lifesciences Financial Deals and Alliances 46
Terumo Corporation, Medical Equipment, Deals By Year, 2009 to YTD 2015 46
Terumo Corporation, Medical Equipment, Deals By Type, 2009 to YTD 2015 47
Terumo Corporation, Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 48
Terumo Corporation, Pharmaceuticals and Healthcare, Deals By Type, 2009 to YTD 2015 49
Terumo Corporation, Recent Deals Summary 50
Section 5 - Company's Recent Developments 51
Jul 01, 2015: OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo 51
Jun 01, 2015: MicroVention to Locate Its New 205,000 Square-Foot Worldwide Headquarters At Summit Office Campus in Aliso Viejo 52
Apr 17, 2015: Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant 53
Apr 06, 2015: Terumo and Olympus Expand Interventional System Business Partnership 54
Apr 02, 2015: Terumo announces CE mark approvals for LIFEPEARL and HYDROPEARL microspheres 55
Mar 19, 2015: Scientists at Nelson Laboratories Discover Extractable Positive Control for In Vitro Skin Irritation Testing of Medical Devices 56
Feb 12, 2015: Terumo Establishes a New RD Center for Interventional Business in Southern California, US to Accelerate Worldwide Growth of Interventional Therapeutic Area 57
Feb 11, 2015: New device improves healing of some ruptured aneurysms 58
Jan 26, 2015: Terumo Cardiovascular Group Announces Expansion Of Its Elkton, Maryland Manufacturing Facility 59
Dec 25, 2014: Terumo Commences Sales of Tercross PTA Balloon Catheters in Europe 60
Section 6 - Appendix 61
Methodology 61
Ratio Definitions 61
About GlobalData 65
Contact Us 65
Disclaimer 65

List of Tables
Terumo Corporation, Key Facts 6
Terumo Corporation, Key Employees 7
Terumo Corporation, Key Employee Biographies 10
Terumo Corporation, Key Operational Employees 11
Terumo Corporation, Major Products and Services 12
Terumo Corporation Number of Pipeline Products by Equipment Type 14
Terumo Corporation Pipeline Products by Equipment Type 15
Terumo Corporation Number of Pipeline Products by Development Stage 17
Terumo Corporation Pipeline Products by Development Stage 18
Terumo Corporation, History 19
Terumo Corporation, Other Locations 27
Terumo Corporation, Subsidiaries 28
Terumo Corporation, Joint Venture 30
Terumo Corporation, Key Competitors 39
Terumo Corporation, Ratios based on current share price 40
Terumo Corporation, Annual Ratios 41
Terumo Corporation, Interim Ratios 44
Terumo Corporation, Medical Equipment, Deals By Year, 2009 to YTD 2015 46
Terumo Corporation, Medical Equipment, Deals By Type, 2009 to YTD 2015 47
Terumo Corporation, Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 48
Terumo Corporation, Pharmaceuticals and Healthcare, Deals By Type, 2009 to YTD 2015 49
Terumo Corporation, Recent Deals Summary 50
Currency Codes 61
Capital Market Ratios 61
Equity Ratios 62
Profitability Ratios 62
Cost Ratios 63
Liquidity Ratios 63
Leverage Ratios 64
Efficiency Ratios 64

List of Figures
Terumo Corporation Pipeline Products by Equipment Type 14
Terumo Corporation Pipeline Products by Development Stage 17
Terumo Corporation, Performance Chart (2011 - 2015) 43
Terumo Corporation, Ratio Charts 45
Terumo Corporation, Medical Equipment, Deals By Year, 2009 to YTD 2015 46
Terumo Corporation, Medical Equipment, Deals by Type, 2009 to YTD 2015 47
Terumo Corporation, Pharmaceuticals and Healthcare, Deals By Year, 2009 to YTD 2015 48
Terumo Corporation, Pharmaceuticals and Healthcare, Deals by Type, 2009 to YTD 2015 49

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.